SECTION 3
Current research processes and infrastructure can’t fully support the requirements of cell and gene therapy protocol development and delivery. Now is the time for new approaches, to futureproof clinical development as the product pipeline continues to grow. This section offers a vision for how stakeholders could collaborate to expand the number of CAGT clinical research sites, and a case study of how advanced analytics support clinical development.
Stay current with novel thinking and actionable insights from our experts.
At Parexel, we deliver innovative trial designs, built on a deep understanding of the patient journey. Our Cell and Gene Therapy Center of Excellence aggregates best practices from across the development lifecycle to help our customers navigate frequently changing regulatory hurdles and accelerate the treatment journey to patients. Parexel supports sponsors to take control of their regulatory path and reduce compliance risks to deliver a faster, smarter route from proof of concept to marketing authorization.
Accelerate your cell and gene therapy development and maximize the chances of market success with Parexel.